Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

243.00
-4.1600-1.68%
Pre-market: 243.000.00000.00%05:42 EDT
Volume:328.12K
Turnover:79.90M
Market Cap:6.81B
PE:-3.72
High:246.82
Open:245.00
Low:241.87
Close:247.16
Loading ...

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Zacks
·
31 Oct 2024

SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference

GlobeNewswire
·
31 Oct 2024

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

PR Newswire
·
31 Oct 2024

RBC Capital Sticks to Their Buy Rating for Bio-Rad Laboratories (BIO)

TIPRANKS
·
31 Oct 2024

Bio Rad Laboratories Inc : Citigroup Raises Target Price to $450 From $400

THOMSON REUTERS
·
31 Oct 2024

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...

GuruFocus.com
·
31 Oct 2024

Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit

Reuters
·
31 Oct 2024

Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates

Zacks
·
31 Oct 2024

Bio-Rad: Q3 Earnings Snapshot

Associated Press Finance
·
31 Oct 2024

Bio-Rad Laboratories Q3 2024 Adj. EPS $2.01 Beats $1.16 Estimate, Sales $649.729M Beat $628.174M Estimate

Benzinga
·
31 Oct 2024

Bio-Rad sees non-GAAP revenue down 2.5%-4% for FY24

TIPRANKS
·
31 Oct 2024

BRIEF-Bio-Rad Q3 Adjusted EPS USD 2.01 Vs. IBES Estimate USD 1.16

Reuters
·
31 Oct 2024

Bio Rad Laboratories- Continues to Expect Non-Gaap Revenue to Decline by About 2.5 to 4.0 Percent on a Currency-Neutral Basis for 2024

THOMSON REUTERS
·
31 Oct 2024

Bio-Rad Q3 EBIT Margin 9.9%

THOMSON REUTERS
·
31 Oct 2024

Press Release: BIO-TECHNE DECLARES DIVIDEND

Dow Jones
·
30 Oct 2024

What to Expect From These 3 MedTech Stocks This Earnings Season

Zacks
·
29 Oct 2024